Blocked from the federal medical marijuana testing system, dispensaries are creating their own
VANCOUVER— The Canadian Association of Medical Cannabis Dispensaries (CAMCD) is moving to set up testing standards and protocols to ensure the safety of the cannabis member dispensaries are selling.
Association President Jeremy Jacob says, “We believe consumers should be empowered to make educated choices about the cannabis products they buy, so we are moving to set up a rigorous, independent and transparent cannabis testing system.”
CAMCD promotes a regulated community-based approach to cannabis access with member dispensaries across Canada serving over 150,000 consumers.
Store front cannabis dispensaries are not allowed to test their product through federally licensed laboratories. Jacob says CAMCD is setting up its own testing standards after federally licensed medical marijuana producers recalled cannabis contaminated with the chemicals bifenazate and myclobutanil in November and December 2016, and were slow to inform the public.
“Dispensary clients need to know the product is free of contaminants. Consumers should be able to see testing results,” says Jacob. “Some of our member dispensaries are already testing their product privately, but we need a system where all are able to test their product, the labs are independent, and the consumer can rely on the results.”
The CAMCD board has created a working group with dispensary owners, cannabis producers, processors, and lab owners, to create guidelines and structure for the testing program. The board wants the system to be in place by May 2017.
Association President Jeremy Jacob will be available for questions today at 4:30 PST
Michael Davis 604.704.7526